Article info
Editorial
Is ex vivo adenovirus mediated gene transfer a therapeutic option for the treatment of corneal diseases?
- Correspondence to: Thomas Ritter PhD, Institute of Medical Immunology, Charité–University Medicine Berlin, Campus Mitte, Monbijoustrasse 2a, 10117 Berlin, Germany; thomas.rittercharite.de
Citation
Is ex vivo adenovirus mediated gene transfer a therapeutic option for the treatment of corneal diseases?
Publication history
- First published May 27, 2005.
Online issue publication
May 27, 2005
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 British Journal of Ophthalmology